Innovative machine learning approach for liver fibrosis and disease severity evaluation in MAFLD patients using MRI fat content analysis.

Journal: Clinical and experimental medicine
Published Date:

Abstract

This study employed machine learning models to quantitatively analyze liver fat content from MRI images for the evaluation of liver fibrosis and disease severity in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). A total of 26 confirmed MAFLD cases, along with MRI image sequences obtained from public repositories, were included to perform a comprehensive assessment. Radiomics features-such as contrast, correlation, homogeneity, energy, and entropy-were extracted and used to construct a random forest classification model with optimized hyperparameters. The model achieved outstanding performance, with an accuracy of 96.8%, sensitivity of 95.7%, specificity of 97.8%, and an F1-score of 96.8%, demonstrating its strong capability in accurately evaluating the degree of liver fibrosis and overall disease severity in MAFLD patients. The integration of machine learning with MRI-based analysis offers a promising approach to enhancing clinical decision-making and guiding treatment strategies, underscoring the potential of advanced technologies to improve diagnostic precision and disease management in MAFLD.

Authors

  • Mengting Hou
    Department of Radiology, Zhejiang Hospital, Hangzhou, Zhejiang Province, China.
  • Yujie Zhu
    Department of Mechanical and Electrical Engineering, Jiangsu Food & Pharmaceutical Science College, Huai'an, China.
  • Huadi Zhou
    Department of Radiology, Zhejiang Hospital, Hangzhou, Zhejiang Province, China.
  • Siyi Zhou
    Department of Radiology, Zhejiang Hospital, Hangzhou, Zhejiang Province, China.
  • Jianjun Zhang
    Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Yue Zhang
    Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Xiao Liu